Want to see TSE:NARA full AI Analyst Report?
Total Valuation
PanGenomic Health, Inc. Class A has a market cap or net worth of C$2.25M. The enterprise value is C$10.18M.
Market CapC$2.25M
Enterprise ValueC$10.18M
Share Statistics
PanGenomic Health, Inc. Class A has 14,046,870 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,046,870
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PanGenomic Health, Inc. Class A’s return on equity (ROE) is 1.57 and return on invested capital (ROIC) is 173.17%.
Return on Equity (ROE)1.57
Return on Assets (ROA)-21.33
Return on Invested Capital (ROIC)173.17%
Return on Capital Employed (ROCE)1.56
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PanGenomic Health, Inc. Class A is ―. PanGenomic Health, Inc. Class A’s PEG ratio is 0.03.
PE Ratio―
PS Ratio0.00
PB Ratio-3.87
Price to FCF-4.51
Price to Operating Cash Flow-1.85
PEG Ratio0.03
Income Statement
In the last 12 months, PanGenomic Health, Inc. Class A had revenue of 0.00 and earned -3.43M in profits. Earnings per share was -0.19.
Revenue0.00
Gross Profit-628.00
Operating Income-3.42M
Pretax Income-3.43M
Net Income-3.43M
EBITDA-3.42M
Earnings Per Share (EPS)-0.19
Cash Flow
In the last 12 months, operating cash flow was -2.21M and capital expenditures 0.00, giving a free cash flow of -2.21M billion.
Operating Cash Flow-2.21M
Free Cash Flow-2.21M
Free Cash Flow per Share-0.16
Dividends & Yields
PanGenomic Health, Inc. Class A pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.21
52-Week Price Change-92.00%
50-Day Moving Average0.30
200-Day Moving Average0.39
Relative Strength Index (RSI)26.55
Average Volume (3m)1.15K
Important Dates
PanGenomic Health, Inc. Class A upcoming earnings date is Nov 26, 2026, Before Open (Confirmed).
Last Earnings DateAug 31, 2026
Next Earnings DateNov 26, 2026
Ex-Dividend Date―
Financial Position
PanGenomic Health, Inc. Class A as a current ratio of 0.07, with Debt / Equity ratio of -25.97%
Current Ratio0.07
Quick Ratio0.07
Debt to Market Cap0.03
Net Debt to EBITDA-0.05
Interest Coverage Ratio-835.72
Taxes
In the past 12 months, PanGenomic Health, Inc. Class A has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
PanGenomic Health, Inc. Class A EV to EBITDA ratio is -2.53, with an EV/FCF ratio of -4.60.
EV to Sales0.00
EV to EBITDA-2.53
EV to Free Cash Flow-4.60
EV to Operating Cash Flow-4.60
Balance Sheet
PanGenomic Health, Inc. Class A has C$7.72K in cash and marketable securities with C$715.34K in debt, giving a net cash position of -C$707.62K billion.
Cash & Marketable SecuritiesC$7.72K
Total DebtC$715.34K
Net Cash-C$707.62K
Net Cash Per Share-C$0.05
Tangible Book Value Per Share-C$0.12
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for PanGenomic Health, Inc. Class A is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast43.30%